Antibodies
8 June 2007
Remicade(R) Receives EU Approval as First and Only Biologic Treatment for Pediatric Crohn’s Disease8 June 2007
Abbott’s HUMIRA(R) (Adalimumab) Approved in the European Union for the Treatment of Crohn’s Disease6 June 2007
Data Demonstrated Metastatic Melanoma Response to Investigational Immunotherapy Ipilimumab6 June 2007
Phase I Results for ImClone Pipeline Anti-IGF-1R Monoclonal Antibody IMC-A12 Presented at ASCO4 June 2007
Genentech Provides Update on Pipeline Agents at The American Society of Clinical Oncology Meeting25 May 2007
MedImmune Highlights Advances in Inflammatory Disease Pipeline With Series of Data Presentations23 May 2007
Lpath Demonstrates ‘First-in-Class’ AMD Results With Its Lead Drug Candidate, Sphingomab(TM)News Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
Subscribe
Newsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
Subscribe
Featured reports